Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cyclo Therapeutics Inc
(NQ:
CYTH
)
1.280
-0.020 (-1.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cyclo Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Fed Speakers
November 17, 2021
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after closing mostly flat in the prior session. Investors are awaiting earnings results from Lowe`s...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
5 Stocks To Watch For November 17, 2021
November 17, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Lowe`s Companies Inc (NYSE: LOW) to report quarterly earnings at $2.35 per share on revenue of $...
Via
Benzinga
Cyclo Therapeutics Announces Pricing of $11.7 Million Underwritten Public Offering of Common Stock
November 16, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces Proposed Public Offering of Common Stock
November 16, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Shares Jump After Filing To Start Alzheimer's Trial In US
November 16, 2021
Cyclo Therapeutics Inc (NASDAQ: CYTH) has submitted its initial investigational new drug (IND) application with the FDA for a Phase 2 study of Trappsol Cyclo for...
Via
Benzinga
Exposures
Product Safety
Cyclo Therapeutics Submits Investigational New Drug Application to U.S. FDA to Advance Trappsol® Cyclo™ in Phase 2 Study for Treatment of Alzheimer’s Disease
November 16, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
November 15, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics to Present at the Virtual Investor Roundtable Event
November 10, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th
November 04, 2021
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating...
From
JTC Team, LLC
Via
AccessWire
Cyclo Therapeutics Names Preeminent Neuroscientist and World-Renowned Researcher, Cynthia A. Lemere, PhD, as Senior Advisor for Advancement of Alzheimer’s Disease Asset
November 02, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Recognizes Niemann-Pick Disease Awareness Month Highlighting Need for Broader Awareness and Support for Research to Find a Treatment
October 19, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the 14th International Congress of Inborn Errors of Metabolism (ICIEM)
October 18, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics to Participate in the 2021 Virtual Cyclodextrin Conference Hosted by CycloLab
October 06, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Appoints Lise Lund Kjems, MD, PhD as Chief Medical Officer
September 27, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
September 15, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
September 08, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
August 17, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics' Trappsol Shows Early Safety, Efficacy In Genetic Disorder
July 30, 2021
Cyclo Therapeutics Inc (NASDAQ: CYTH) has announced new data from its Phase 1 extension study evaluating Trappsol Cyclo Niemann-Pick Disease Type C1 (NPC), a...
Via
Benzinga
Cyclo Therapeutics Announces New Positive Safety and Efficacy Data from Ongoing Phase 1 Open-Label Extension Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1
July 30, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Commences Commercial-Scale Manufacturing for Trappsol® Cyclo™
July 27, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 22, 2021
Gainers vTv Therapeutics (NASDAQ:VTVT) shares rose 30.08% to $3.07 during Tuesday's pre-market session. The company's market cap stands at $251.7 million. Adial...
Via
Benzinga
Cyclo Therapeutics to Present at the 2021 NPC Patient and Family Conference Hosted by the Australian NPC Disease Foundation
June 21, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Shares Move Higher On Kickstart Of Late-Stage NPC Trial With Trappsol Cyclo
June 17, 2021
Cyclo Therapeutics Inc (NASDAQ: CYTH) has commenced its pivotal Phase 3 study (TransportNPC) evaluating Trappsol Cyclo for Niemann-Pick Disease Type C1 (NPC1). The...
Via
Benzinga
Cyclo Therapeutics Commences Patient Enrollment in TransportNPC, a Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
June 17, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics Announces Launch of New Website
June 15, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
June 14, 2021
Gainers RAPT Therapeutics (NASDAQ:RAPT) s...
Via
Benzinga
Cyclo Therapeutics Announces Inclusion in the Russell 2000® Index
June 14, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
Cyclo Therapeutics to Present at the JMP Securities Life Sciences Conference
June 09, 2021
From
Cyclo Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 24, 2021
Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 21, 2021
Gainers Gracell Biotechnologies (NASDAQ:GRCL) shares rose 21.25% to $17.69 during Friday's regular session. Trading volume for Gracell Biotechnologies's stock is...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.